CTLLABHealthcare Service Provider
Clinitech Laboratory Ltd — Profit & Loss Statement
₹35.00
-6.23%
Clinitech Laboratory Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -72536.76 | -41041.30 | — |
| Tax Rate For Calcs | 0.29 | 0.27 | 0.29 | 0.27 | — |
| Normalized EBITDA | 1.06 Cr | 1.04 Cr | 1.39 Cr | 1.14 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 0.39 Cr | 0.37 Cr | 0.61 Cr | 0.51 Cr | — |
| Reconciled Depreciation | 0.45 Cr | 0.44 Cr | 0.45 Cr | 0.38 Cr | — |
| Reconciled Cost Of Revenue | 1.83 Cr | 1.34 Cr | 1.39 Cr | 1.80 Cr | — |
| EBITDA | 1.06 Cr | 1.04 Cr | 1.37 Cr | 1.12 Cr | — |
| EBIT | 0.61 Cr | 0.60 Cr | 0.92 Cr | 0.74 Cr | — |
| Net Interest Income | -0.06 Cr | -0.09 Cr | -0.06 Cr | -0.05 Cr | — |
| Interest Expense | 0.06 Cr | 0.09 Cr | 0.06 Cr | 0.04 Cr | — |
| Normalized Income | 0.39 Cr | 0.37 Cr | 0.63 Cr | 0.52 Cr | — |
| Net Income From Continuing And Discontinued Operation | 0.39 Cr | 0.37 Cr | 0.61 Cr | 0.51 Cr | — |
| Total Expenses | 7.85 Cr | 5.84 Cr | 5.40 Cr | 5.63 Cr | — |
| Diluted NI Availto Com Stockholders | 0.39 Cr | 0.37 Cr | 0.61 Cr | 0.51 Cr | — |
| Net Income Common Stockholders | 0.39 Cr | 0.37 Cr | 0.61 Cr | 0.51 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 0.39 Cr | 0.37 Cr | 0.61 Cr | 0.51 Cr | — |
| Net Income Including Noncontrolling Interests | 0.39 Cr | 0.37 Cr | 0.61 Cr | 0.51 Cr | — |
| Net Income Continuous Operations | 0.39 Cr | 0.37 Cr | 0.61 Cr | 0.51 Cr | — |
| Tax Provision | 0.16 Cr | 0.13 Cr | 0.25 Cr | 0.19 Cr | — |
| Pretax Income | 0.55 Cr | 0.51 Cr | 0.86 Cr | 0.70 Cr | — |
| Other Non Operating Income Expenses | 0.23 Cr | 0.04 Cr | — | 19000.00 | — |
| Net Non Operating Interest Income Expense | -0.06 Cr | -0.09 Cr | -0.06 Cr | -0.05 Cr | — |
| Interest Expense Non Operating | 0.06 Cr | 0.09 Cr | 0.06 Cr | 0.04 Cr | — |
| Operating Income | 0.38 Cr | 0.56 Cr | 0.95 Cr | 0.76 Cr | — |
| Operating Expense | 6.02 Cr | 4.51 Cr | 4.01 Cr | 3.83 Cr | — |
| Other Operating Expenses | 2.71 Cr | 1.78 Cr | 0.25 Cr | 0.23 Cr | — |
| Depreciation And Amortization In Income Statement | 0.45 Cr | 0.44 Cr | 0.45 Cr | 0.38 Cr | — |
| Depreciation Income Statement | 0.45 Cr | 0.44 Cr | 0.45 Cr | 0.38 Cr | — |
| Gross Profit | 6.40 Cr | 5.07 Cr | 4.96 Cr | 4.59 Cr | — |
| Cost Of Revenue | 1.83 Cr | 1.34 Cr | 1.39 Cr | 1.80 Cr | — |
| Total Revenue | 8.23 Cr | 6.40 Cr | 6.35 Cr | 6.38 Cr | — |
| Operating Revenue | 8.23 Cr | 6.40 Cr | 6.35 Cr | 6.38 Cr | — |
| Total Unusual Items | — | 0.01 Cr | -0.03 Cr | -0.02 Cr | 0.02 Cr |
| Total Unusual Items Excluding Goodwill | — | 0.01 Cr | -0.03 Cr | -0.02 Cr | 0.02 Cr |
| Interest Income | — | 1000.00 | 76000.00 | 57000.00 | 1000.00 |
| Rent Expense Supplemental | — | 0.52 Cr | 0.57 Cr | 0.62 Cr | 0.50 Cr |
| Diluted Average Shares | — | 0.23 Cr | 0.23 Cr | 0.23 Cr | 0.23 Cr |
| Basic Average Shares | — | 0.23 Cr | 0.23 Cr | 0.23 Cr | 0.23 Cr |
| Diluted EPS | — | 1.63 | 2.69 | 2.25 | 1.76 |
| Basic EPS | — | 1.63 | 2.69 | 2.25 | 1.76 |
| Net Income Extraordinary | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Special Income Charges | — | 0.01 Cr | -0.03 Cr | -0.02 Cr | -0.01 Cr |
| Other Special Charges | — | -0.01 Cr | — | 1000.00 | — |
| Write Off | — | 0.00 | 0.03 Cr | 0.02 Cr | 0.01 Cr |
| Total Other Finance Cost | — | 0.02 Cr | 0.01 Cr | 0.02 Cr | 46000.00 |
| Interest Income Non Operating | — | 1000.00 | 76000.00 | 57000.00 | 1000.00 |
| Selling General And Administration | — | 0.92 Cr | 0.72 Cr | 0.82 Cr | 0.56 Cr |
| Selling And Marketing Expense | — | 0.07 Cr | 0.07 Cr | 0.12 Cr | 0.10 Cr |
| General And Administrative Expense | — | 0.86 Cr | 0.65 Cr | 0.71 Cr | 0.46 Cr |
| Rent And Landing Fees | — | 0.52 Cr | 0.57 Cr | 0.62 Cr | 0.50 Cr |
| Amortization | — | — | 31000.00 | — | 12000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Clinitech Laboratory Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.